| Abstrakt: |
Genome editing techniques (GETs) could support the transition towards a circular bio-based economy. This would require a regulatory framework that enables technical and scientific progress while ensuring safety for humans and environment. In this context, there is a debate among stakeholders in Europe whether products resulting from GETs should be subject to the GMO legislation. This paper analyses different stakeholder positions and underlying arguments on this question based on the Politically Inherent Dynamics Approach (PIDA). This takes into consideration the role of actor interests, the problem structure, institutions and alternative instruments. The analysis, based on a series of expert interviews and a Delphi survey, reveals that differing stakeholder positions are strongly shaped by differing beliefs and interests. This leads to a divergence in the definition of the problem structure, and the related solutions, in terms of the institutional set-up and alternative instruments considered. It highlights the need to reach a shared vision among actors of the problems that need to be solved, in order to understand if GETs can be considered as one potential 'solution', embracing the precautionary and innovation principles. Alternative instruments are proposed, including a call for higher stakeholder engagement and diverse regulatory instruments. [ABSTRACT FROM AUTHOR] |
